IL17A and psoriasis: Salivary interleukins, including IL-1β, IL-6, TNF-α, and IL-17, offer significant results as non-invasive biomarkers for early detection, severity assessment, and treatment monitoring of psoriasis, effectively reflecting systemic inflammation.